These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12069290)

  • 1. The effects of early insulin treatment combined with thrombolysis in rat embolic stroke.
    Meden P; Andersen M; Overgaard K; Rasmussen RS; Boysen G
    Neurol Res; 2002 Jun; 24(4):399-404. PubMed ID: 12069290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model.
    Andersen M; Overgaard K; Meden P; Boysen G; Choi SC
    Stroke; 1999 Jul; 30(7):1464-71. PubMed ID: 10390324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of infarct volume by thrombolysis with rt-PA in an embolic rat stroke model.
    Overgaard K; Sereghy T; Boysen G; Pedersen H; Diemer NH
    Scand J Clin Lab Invest; 1993 Jul; 53(4):383-93. PubMed ID: 8378742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke.
    Overgaard K; Sereghy T; Pedersen H; Boysen G
    Neurol Res; 1993 Oct; 15(5):344-9. PubMed ID: 7905610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.
    Alonso de Leciñana M; Gutiérrez M; Roda JM; Carceller F; Díez-Tejedor E
    J Neurol Sci; 2006 Sep; 247(2):121-9. PubMed ID: 16797595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model.
    Overgaard K; Sereghy T; Pedersen H; Boysen G
    J Cereb Blood Flow Metab; 1994 May; 14(3):472-7. PubMed ID: 8163589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response of rt-PA and its combination with aspirin in a rat embolic stroke model.
    Overgaard K; Sereghy T; Pedersen H; Boysen G
    Neuroreport; 1992 Oct; 3(10):925-8. PubMed ID: 1421100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats.
    Sereghy T; Overgaard K; Boysen G
    Stroke; 1993 Nov; 24(11):1702-8. PubMed ID: 8236347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of infarct volume and mortality by thrombolysis in a rat embolic stroke model.
    Overgaard K; Sereghy T; Boysen G; Pedersen H; Diemer NH
    Stroke; 1992 Aug; 23(8):1167-73; discussion 1174. PubMed ID: 1636193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of body temperature on infarct volume and thrombolytic therapy in a rat embolic stroke model.
    Meden P; Overgaard K; Pedersen H; Boysen G
    Brain Res; 1994 May; 647(1):131-8. PubMed ID: 8069695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing the efficacy of thrombolysis by AMPA receptor blockade with NBQX in a rat embolic stroke model.
    Meden P; Overgaard K; Sereghy T; Boysen G
    J Neurol Sci; 1993 Nov; 119(2):209-16. PubMed ID: 8277337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monteplase reduces infarct volume and hemorrhagic transformation in rat model of embolic stroke.
    Muramatsu H; Igarashi H; Okubo S; Katayama Y
    Neurol Res; 2002 Apr; 24(3):311-6. PubMed ID: 11958428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined systemic thrombolysis with alteplase and early hyperbaric oxygen therapy in experimental embolic stroke in rats: relationship to functional outcome and reduction of structural damage.
    Küppers-Tiedt L; Manaenko A; Michalski D; Guenther A; Hobohm C; Wagner A; Zhang JH; Schneider D
    Acta Neurochir Suppl; 2011; 111():167-72. PubMed ID: 21725750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of albumin prior to delayed thrombolysis reduces brain edema and blood brain barrier permeability in an embolic stroke model.
    Lu HT; Zhao JG; Li MH; Li YD
    Brain Res; 2012 Feb; 1438():75-84. PubMed ID: 22227456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK-506 extended the therapeutic time window for thrombolysis without increasing the risk of hemorrhagic transformation in an embolic rat stroke model.
    Okubo S; Igarashi H; Kanamatsu T; Hasegawa D; Orima H; Katayama Y
    Brain Res; 2007 Apr; 1143():221-7. PubMed ID: 17316578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new rat model of thrombotic focal cerebral ischemia.
    Zhang Z; Zhang RL; Jiang Q; Raman SB; Cantwell L; Chopp M
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):123-35. PubMed ID: 9040491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke.
    Zhang L; Zhang ZG; Zhang RL; Lu M; Krams M; Chopp M
    Stroke; 2003 Jul; 34(7):1790-5. PubMed ID: 12805500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early (1 h) administration of tissue plasminogen activator reduces infarct volume without increasing hemorrhagic transformation after focal cerebral embolization in rats.
    Zhang RL; Chopp M; Zhang ZG; Divine G
    J Neurol Sci; 1998 Sep; 160(1):1-8. PubMed ID: 9804110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome.
    Sun X; Berthiller J; Derex L; Trouillas P; Diallo L; Hanss M
    J Neurol Sci; 2015 Feb; 349(1-2):77-83. PubMed ID: 25619569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection afforded by a combination of eliprodil and a thrombolytic agent, rt-PA, in a rat thromboembolic stroke model.
    Lekieffre D; Benavides J; Scatton B; Nowicki JP
    Brain Res; 1997 Nov; 776(1-2):88-95. PubMed ID: 9439799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.